Automatic Injectors Professional Market Size and Forecasts (2021 - 2031), Global and Regional Share, Trends, and Growth Opportunity Analysis
An automatic injector is a syringe with a pre-charged dose of medicines and a spring-charged needle. When inserted into the body with a sliding motion, the device activates and administers a measured dosage of a medicament. Autoinjectors are routinely used for self-administration of epinephrine (to avoid anaphylaxis), migraine patients (for rapid pain relief), and medical and emergency treatments. Auto-injectors have a number of advantages, including reducing needle-related phobia condition, reducing the risk of needle-stick incidents, maintaining dose quality consistency, and helping with increased effectiveness.
MARKET SCOPE
The Global Automatic Injectors Professional Market Analysis to 2028 is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of the automatic injectors professional market with detailed market segmentation by therapy, type, route of administration and end user. The report provides key statistics on the market status of the leading automatic injectors professional market players and offers key trends and opportunities in the market.
MARKET SEGMENTATION
- Based on therapy the market is segmented as, RA, multiple sclerosis, diabetes, anaphylaxis, other therapies.
- Based on type the market is segmenetd as, disposable autoinjectors, resusable autoinjectors.
- Based on route of administration the market is segmenetd as, subcutaneous and IM.
- Based on end user the market is segmenetd as, home care setting, hospitals and clinics, ambulatory care settings.
MARKET DYNAMICS
Drivers:
- Growing cases of anaphylaxis disorders and other chronic diseases.
- Rising trend for self administration of medicaments due to growth in demand for homecare settings.
- Consistent R&D efforts for developing simple, cost-effective, and innovative technology-based autoinjectors for the treatment of chronic diseases such rheumatoid arthritis and multiple sclerosis are likely to fuel market growth throughout the forecast period.
- Increasing number of new product approvals and new product launches are also expected to spur market growth.
Restraints:
- However, availability of alternative treatment options is expected to restrain market growth during the forecast period.
REGIONAL FRAMEWORK
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides an overview and forecast of the global market based on various segments. It also provides market size and forecast estimates from the year 2019 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), the Middle East and Africa (MEA), and South America. The automatic injectors professional market by each region is later sub-segmented by respective countries and segments. The report covers the analysis and forecast of 18 countries globally along with the current trend and opportunities prevailing in the region.
The report analyzes factors affecting the market from both demand and supply side and further evaluates market dynamics affecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA, and South America after evaluating political, economic, social and technological factors affecting the automatic injectors professional market in these regions.
IMPACT OF COVID-19 ON AUTOMATIC INJECTORS PROFESSIONAL MARKET
COVID-19 first began in Wuhan (China) during December 2019 and since then it has spread at a fast pace across the globe. The US, India, Brazil, Russia, France, the UK, Turkey, Italy, and Spain are some of the worst affected countries in terms confirmed cases and reported deaths. The COVID-19 has been affecting economies and industries in various countries due to lockdowns, travel bans, and business shutdowns. Shutdown of various plants and factories has affected the global supply chains and negatively impacted the manufacturing, delivery schedules, and sales of products in global market. Few companies have already announced possible delays in product deliveries and slump in future sales of their products. According to the current market situation, the report further assesses the present and future effects of the COVID-19 pandemic on the overall market, giving more reliable and authentic projections In addition to this, the global travel bans imposed by countries in Europe, Asia-Pacific, and North America are affecting the business collaborations and partnerships opportunities.
![World Geography](https://www.theinsightpartners.com/assets/rdimages/world-geography.png)
Have a question?
![Analyst](https://www.theinsightpartners.com/assets/mrinal_kerhalkar.jpg)
Mrinal
Mrinal will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
![Analyst](https://www.theinsightpartners.com/assets/images/speak_analyst.gif)
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides an overview and forecast of the global market based on various segments. It also provides market size and forecast estimates from the year 2019 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), the Middle East and Africa (MEA), and South America. The automatic injectors professional market by each region is later sub-segmented by respective countries and segments. The report covers the analysis and forecast of 18 countries globally along with the current trend and opportunities prevailing in the region.
The report analyzes factors affecting the market from both demand and supply side and further evaluates market dynamics affecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA, and South America after evaluating political, economic, social and technological factors affecting the automatic injectors professional market in these regions.
IMPACT OF COVID-19 ON AUTOMATIC INJECTORS PROFESSIONAL MARKET
COVID-19 first began in Wuhan (China) during December 2019 and since then it has spread at a fast pace across the globe. The US, India, Brazil, Russia, France, the UK, Turkey, Italy, and Spain are some of the worst affected countries in terms confirmed cases and reported deaths. The COVID-19 has been affecting economies and industries in various countries due to lockdowns, travel bans, and business shutdowns. Shutdown of various plants and factories has affected the global supply chains and negatively impacted the manufacturing, delivery schedules, and sales of products in global market. Few companies have already announced possible delays in product deliveries and slump in future sales of their products. According to the current market situation, the report further assesses the present and future effects of the COVID-19 pandemic on the overall market, giving more reliable and authentic projections In addition to this, the global travel bans imposed by countries in Europe, Asia-Pacific, and North America are affecting the business collaborations and partnerships opportunities.
MARKET PLAYERS
The report covers key developments in the automatic injectors professional market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the marketwere acquisitions, and partnership & collaborations. These activities have paved way for the expansion of business and customer base of market players. The market payers from automatic injectors professional market are anticipated to lucrative growth opportunities in the future with the rising demand for Automatic injectors professional in the global market.
The report also includes the profiles of key companies along with their SWOT analysis and market strategies in the automatic injectors professional market. In addition, the report focuses on leading industry players with information such as company profiles, components, and services offered, financial information of the last 3 years, the key development in the past five years.
- Eisai Co., Ltd
- Viatris Inc
- Ypsomed
- Amgen, Inc
- BD
- Teva Pharmaceuticals USA, Inc
- Antares Pharma
- Merck KGaA
- Owen Mumford
- Biogen
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
![Report Coverage](https://www.theinsightpartners.com/assets/rdimages/report_coverage.png)
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
![Segment Covered](https://www.theinsightpartners.com/assets/rdimages/segment_covered.png)
Segment Covered
This text is related
to segments covered.
![Regional Scope](https://www.theinsightpartners.com/assets/rdimages/regional_scope.png)
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
![Country Scope](https://www.theinsightpartners.com/assets/rdimages/country_scope.png)
Country Scope
This text is related
to country scope.
1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Automatic Injectors Professional Market - By Therapy
1.3.2 Automatic Injectors Professional Market - By Type
1.3.3 Automatic Injectors Professional Market - By Route of administration
1.3.4 Automatic Injectors Professional Market - By End User
1.3.5 Automatic Injectors Professional Market - By Region
1.3.5.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. AUTOMATIC INJECTORS PROFESSIONAL MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PORTER'S FIVE FORCES ANALYSIS
4.2.1 Bargaining Power of Buyers
4.2.1 Bargaining Power of Suppliers
4.2.1 Threat of Substitute
4.2.1 Threat of New Entrants
4.2.1 Competitive Rivalry
4.3. EXPERT OPINIONS
5. AUTOMATIC INJECTORS PROFESSIONAL MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. AUTOMATIC INJECTORS PROFESSIONAL MARKET - GLOBAL MARKET ANALYSIS
6.1. AUTOMATIC INJECTORS PROFESSIONAL - GLOBAL MARKET OVERVIEW
6.2. AUTOMATIC INJECTORS PROFESSIONAL - GLOBAL MARKET AND FORECAST TO 2028
6.3. MARKET POSITIONING/MARKET SHARE
7. AUTOMATIC INJECTORS PROFESSIONAL MARKET - REVENUE AND FORECASTS TO 2028 - THERAPY
7.1. OVERVIEW
7.2. THERAPY MARKET FORECASTS AND ANALYSIS
7.3. RHEUMATOID ARTHRITIS
7.3.1. Overview
7.3.2. Rheumatoid Arthritis Market Forecast and Analysis
7.4. MULTIPLE SCLEROSIS
7.4.1. Overview
7.4.2. Multiple Sclerosis Market Forecast and Analysis
7.5. DIABETES
7.5.1. Overview
7.5.2. Diabetes Market Forecast and Analysis
7.6. ANAPHYLAXIS
7.6.1. Overview
7.6.2. Anaphylaxis Market Forecast and Analysis
7.7. OTHER THERAPIES
7.7.1. Overview
7.7.2. Other Therapies Market Forecast and Analysis
8. AUTOMATIC INJECTORS PROFESSIONAL MARKET - REVENUE AND FORECASTS TO 2028 - TYPE
8.1. OVERVIEW
8.2. TYPE MARKET FORECASTS AND ANALYSIS
8.3. DISPOSABLE AUTOINJECTORS
8.3.1. Overview
8.3.2. Disposable Autoinjectors Market Forecast and Analysis
8.4. REUSABLE AUTOINJECTORS
8.4.1. Overview
8.4.2. Reusable Autoinjectors Market Forecast and Analysis
9. AUTOMATIC INJECTORS PROFESSIONAL MARKET - REVENUE AND FORECASTS TO 2028 - ROUTE OF ADMINISTRATION
9.1. OVERVIEW
9.2. ROUTE OF ADMINISTRATION MARKET FORECASTS AND ANALYSIS
9.3. SUBCUTANEOUS
9.3.1. Overview
9.3.2. Subcutaneous Market Forecast and Analysis
9.4. INTRAMUSCULAR
9.4.1. Overview
9.4.2. Intramuscular Market Forecast and Analysis
10. AUTOMATIC INJECTORS PROFESSIONAL MARKET - REVENUE AND FORECASTS TO 2028 - END USER
10.1. OVERVIEW
10.2. END USER MARKET FORECASTS AND ANALYSIS
10.3. HOME CARE SETTINGS
10.3.1. Overview
10.3.2. Home Care Settings Market Forecast and Analysis
10.4. HOSPITALS AND CLINICS
10.4.1. Overview
10.4.2. Hospitals and Clinics Market Forecast and Analysis
10.5. AMBULATORY CARE SETTINGS
10.5.1. Overview
10.5.2. Ambulatory Care Settings Market Forecast and Analysis
11. AUTOMATIC INJECTORS PROFESSIONAL MARKET REVENUE AND FORECASTS TO 2028 - GEOGRAPHICAL ANALYSIS
11.1. NORTH AMERICA
11.1.1 North America Automatic Injectors Professional Market Overview
11.1.2 North America Automatic Injectors Professional Market Forecasts and Analysis
11.1.3 North America Automatic Injectors Professional Market Forecasts and Analysis - By Therapy
11.1.4 North America Automatic Injectors Professional Market Forecasts and Analysis - By Type
11.1.5 North America Automatic Injectors Professional Market Forecasts and Analysis - By Route of administration
11.1.6 North America Automatic Injectors Professional Market Forecasts and Analysis - By End User
11.1.7 North America Automatic Injectors Professional Market Forecasts and Analysis - By Countries
11.1.7.1 United States Automatic Injectors Professional Market
11.1.7.1.1 United States Automatic Injectors Professional Market by Therapy
11.1.7.1.2 United States Automatic Injectors Professional Market by Type
11.1.7.1.3 United States Automatic Injectors Professional Market by Route of administration
11.1.7.1.4 United States Automatic Injectors Professional Market by End User
11.1.7.2 Canada Automatic Injectors Professional Market
11.1.7.2.1 Canada Automatic Injectors Professional Market by Therapy
11.1.7.2.2 Canada Automatic Injectors Professional Market by Type
11.1.7.2.3 Canada Automatic Injectors Professional Market by Route of administration
11.1.7.2.4 Canada Automatic Injectors Professional Market by End User
11.1.7.3 Mexico Automatic Injectors Professional Market
11.1.7.3.1 Mexico Automatic Injectors Professional Market by Therapy
11.1.7.3.2 Mexico Automatic Injectors Professional Market by Type
11.1.7.3.3 Mexico Automatic Injectors Professional Market by Route of administration
11.1.7.3.4 Mexico Automatic Injectors Professional Market by End User
11.2. EUROPE
11.2.1 Europe Automatic Injectors Professional Market Overview
11.2.2 Europe Automatic Injectors Professional Market Forecasts and Analysis
11.2.3 Europe Automatic Injectors Professional Market Forecasts and Analysis - By Therapy
11.2.4 Europe Automatic Injectors Professional Market Forecasts and Analysis - By Type
11.2.5 Europe Automatic Injectors Professional Market Forecasts and Analysis - By Route of administration
11.2.6 Europe Automatic Injectors Professional Market Forecasts and Analysis - By End User
11.2.7 Europe Automatic Injectors Professional Market Forecasts and Analysis - By Countries
11.2.7.1 Germany Automatic Injectors Professional Market
11.2.7.1.1 Germany Automatic Injectors Professional Market by Therapy
11.2.7.1.2 Germany Automatic Injectors Professional Market by Type
11.2.7.1.3 Germany Automatic Injectors Professional Market by Route of administration
11.2.7.1.4 Germany Automatic Injectors Professional Market by End User
11.2.7.2 France Automatic Injectors Professional Market
11.2.7.2.1 France Automatic Injectors Professional Market by Therapy
11.2.7.2.2 France Automatic Injectors Professional Market by Type
11.2.7.2.3 France Automatic Injectors Professional Market by Route of administration
11.2.7.2.4 France Automatic Injectors Professional Market by End User
11.2.7.3 Italy Automatic Injectors Professional Market
11.2.7.3.1 Italy Automatic Injectors Professional Market by Therapy
11.2.7.3.2 Italy Automatic Injectors Professional Market by Type
11.2.7.3.3 Italy Automatic Injectors Professional Market by Route of administration
11.2.7.3.4 Italy Automatic Injectors Professional Market by End User
11.2.7.4 Spain Automatic Injectors Professional Market
11.2.7.4.1 Spain Automatic Injectors Professional Market by Therapy
11.2.7.4.2 Spain Automatic Injectors Professional Market by Type
11.2.7.4.3 Spain Automatic Injectors Professional Market by Route of administration
11.2.7.4.4 Spain Automatic Injectors Professional Market by End User
11.2.7.5 United Kingdom Automatic Injectors Professional Market
11.2.7.5.1 United Kingdom Automatic Injectors Professional Market by Therapy
11.2.7.5.2 United Kingdom Automatic Injectors Professional Market by Type
11.2.7.5.3 United Kingdom Automatic Injectors Professional Market by Route of administration
11.2.7.5.4 United Kingdom Automatic Injectors Professional Market by End User
11.2.7.6 Rest of Europe Automatic Injectors Professional Market
11.2.7.6.1 Rest of Europe Automatic Injectors Professional Market by Therapy
11.2.7.6.2 Rest of Europe Automatic Injectors Professional Market by Type
11.2.7.6.3 Rest of Europe Automatic Injectors Professional Market by Route of administration
11.2.7.6.4 Rest of Europe Automatic Injectors Professional Market by End User
11.3. ASIA-PACIFIC
11.3.1 Asia-Pacific Automatic Injectors Professional Market Overview
11.3.2 Asia-Pacific Automatic Injectors Professional Market Forecasts and Analysis
11.3.3 Asia-Pacific Automatic Injectors Professional Market Forecasts and Analysis - By Therapy
11.3.4 Asia-Pacific Automatic Injectors Professional Market Forecasts and Analysis - By Type
11.3.5 Asia-Pacific Automatic Injectors Professional Market Forecasts and Analysis - By Route of administration
11.3.6 Asia-Pacific Automatic Injectors Professional Market Forecasts and Analysis - By End User
11.3.7 Asia-Pacific Automatic Injectors Professional Market Forecasts and Analysis - By Countries
11.3.7.1 Australia Automatic Injectors Professional Market
11.3.7.1.1 Australia Automatic Injectors Professional Market by Therapy
11.3.7.1.2 Australia Automatic Injectors Professional Market by Type
11.3.7.1.3 Australia Automatic Injectors Professional Market by Route of administration
11.3.7.1.4 Australia Automatic Injectors Professional Market by End User
11.3.7.2 China Automatic Injectors Professional Market
11.3.7.2.1 China Automatic Injectors Professional Market by Therapy
11.3.7.2.2 China Automatic Injectors Professional Market by Type
11.3.7.2.3 China Automatic Injectors Professional Market by Route of administration
11.3.7.2.4 China Automatic Injectors Professional Market by End User
11.3.7.3 India Automatic Injectors Professional Market
11.3.7.3.1 India Automatic Injectors Professional Market by Therapy
11.3.7.3.2 India Automatic Injectors Professional Market by Type
11.3.7.3.3 India Automatic Injectors Professional Market by Route of administration
11.3.7.3.4 India Automatic Injectors Professional Market by End User
11.3.7.4 Japan Automatic Injectors Professional Market
11.3.7.4.1 Japan Automatic Injectors Professional Market by Therapy
11.3.7.4.2 Japan Automatic Injectors Professional Market by Type
11.3.7.4.3 Japan Automatic Injectors Professional Market by Route of administration
11.3.7.4.4 Japan Automatic Injectors Professional Market by End User
11.3.7.5 South Korea Automatic Injectors Professional Market
11.3.7.5.1 South Korea Automatic Injectors Professional Market by Therapy
11.3.7.5.2 South Korea Automatic Injectors Professional Market by Type
11.3.7.5.3 South Korea Automatic Injectors Professional Market by Route of administration
11.3.7.5.4 South Korea Automatic Injectors Professional Market by End User
11.3.7.6 Rest of Asia-Pacific Automatic Injectors Professional Market
11.3.7.6.1 Rest of Asia-Pacific Automatic Injectors Professional Market by Therapy
11.3.7.6.2 Rest of Asia-Pacific Automatic Injectors Professional Market by Type
11.3.7.6.3 Rest of Asia-Pacific Automatic Injectors Professional Market by Route of administration
11.3.7.6.4 Rest of Asia-Pacific Automatic Injectors Professional Market by End User
11.4. MIDDLE EAST AND AFRICA
11.4.1 Middle East and Africa Automatic Injectors Professional Market Overview
11.4.2 Middle East and Africa Automatic Injectors Professional Market Forecasts and Analysis
11.4.3 Middle East and Africa Automatic Injectors Professional Market Forecasts and Analysis - By Therapy
11.4.4 Middle East and Africa Automatic Injectors Professional Market Forecasts and Analysis - By Type
11.4.5 Middle East and Africa Automatic Injectors Professional Market Forecasts and Analysis - By Route of administration
11.4.6 Middle East and Africa Automatic Injectors Professional Market Forecasts and Analysis - By End User
11.4.7 Middle East and Africa Automatic Injectors Professional Market Forecasts and Analysis - By Countries
11.4.7.1 South Africa Automatic Injectors Professional Market
11.4.7.1.1 South Africa Automatic Injectors Professional Market by Therapy
11.4.7.1.2 South Africa Automatic Injectors Professional Market by Type
11.4.7.1.3 South Africa Automatic Injectors Professional Market by Route of administration
11.4.7.1.4 South Africa Automatic Injectors Professional Market by End User
11.4.7.2 Saudi Arabia Automatic Injectors Professional Market
11.4.7.2.1 Saudi Arabia Automatic Injectors Professional Market by Therapy
11.4.7.2.2 Saudi Arabia Automatic Injectors Professional Market by Type
11.4.7.2.3 Saudi Arabia Automatic Injectors Professional Market by Route of administration
11.4.7.2.4 Saudi Arabia Automatic Injectors Professional Market by End User
11.4.7.3 U.A.E Automatic Injectors Professional Market
11.4.7.3.1 U.A.E Automatic Injectors Professional Market by Therapy
11.4.7.3.2 U.A.E Automatic Injectors Professional Market by Type
11.4.7.3.3 U.A.E Automatic Injectors Professional Market by Route of administration
11.4.7.3.4 U.A.E Automatic Injectors Professional Market by End User
11.4.7.4 Rest of Middle East and Africa Automatic Injectors Professional Market
11.4.7.4.1 Rest of Middle East and Africa Automatic Injectors Professional Market by Therapy
11.4.7.4.2 Rest of Middle East and Africa Automatic Injectors Professional Market by Type
11.4.7.4.3 Rest of Middle East and Africa Automatic Injectors Professional Market by Route of administration
11.4.7.4.4 Rest of Middle East and Africa Automatic Injectors Professional Market by End User
11.5. SOUTH AND CENTRAL AMERICA
11.5.1 South and Central America Automatic Injectors Professional Market Overview
11.5.2 South and Central America Automatic Injectors Professional Market Forecasts and Analysis
11.5.3 South and Central America Automatic Injectors Professional Market Forecasts and Analysis - By Therapy
11.5.4 South and Central America Automatic Injectors Professional Market Forecasts and Analysis - By Type
11.5.5 South and Central America Automatic Injectors Professional Market Forecasts and Analysis - By Route of administration
11.5.6 South and Central America Automatic Injectors Professional Market Forecasts and Analysis - By End User
11.5.7 South and Central America Automatic Injectors Professional Market Forecasts and Analysis - By Countries
11.5.7.1 Brazil Automatic Injectors Professional Market
11.5.7.1.1 Brazil Automatic Injectors Professional Market by Therapy
11.5.7.1.2 Brazil Automatic Injectors Professional Market by Type
11.5.7.1.3 Brazil Automatic Injectors Professional Market by Route of administration
11.5.7.1.4 Brazil Automatic Injectors Professional Market by End User
11.5.7.2 Argentina Automatic Injectors Professional Market
11.5.7.2.1 Argentina Automatic Injectors Professional Market by Therapy
11.5.7.2.2 Argentina Automatic Injectors Professional Market by Type
11.5.7.2.3 Argentina Automatic Injectors Professional Market by Route of administration
11.5.7.2.4 Argentina Automatic Injectors Professional Market by End User
11.5.7.3 Rest of South and Central America Automatic Injectors Professional Market
11.5.7.3.1 Rest of South and Central America Automatic Injectors Professional Market by Therapy
11.5.7.3.2 Rest of South and Central America Automatic Injectors Professional Market by Type
11.5.7.3.3 Rest of South and Central America Automatic Injectors Professional Market by Route of administration
11.5.7.3.4 Rest of South and Central America Automatic Injectors Professional Market by End User
12. INDUSTRY LANDSCAPE
12.1. MERGERS AND ACQUISITIONS
12.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
12.3. NEW PRODUCT LAUNCHES
12.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
13. AUTOMATIC INJECTORS PROFESSIONAL MARKET, KEY COMPANY PROFILES
13.1. EISAI CO., LTD
13.1.1. Key Facts
13.1.2. Business Description
13.1.3. Products and Services
13.1.4. Financial Overview
13.1.5. SWOT Analysis
13.1.6. Key Developments
13.2. VIATRIS INC
13.2.1. Key Facts
13.2.2. Business Description
13.2.3. Products and Services
13.2.4. Financial Overview
13.2.5. SWOT Analysis
13.2.6. Key Developments
13.3. YPSOMED
13.3.1. Key Facts
13.3.2. Business Description
13.3.3. Products and Services
13.3.4. Financial Overview
13.3.5. SWOT Analysis
13.3.6. Key Developments
13.4. AMGEN, INC
13.4.1. Key Facts
13.4.2. Business Description
13.4.3. Products and Services
13.4.4. Financial Overview
13.4.5. SWOT Analysis
13.4.6. Key Developments
13.5. BD
13.5.1. Key Facts
13.5.2. Business Description
13.5.3. Products and Services
13.5.4. Financial Overview
13.5.5. SWOT Analysis
13.5.6. Key Developments
13.6. TEVA PHARMACEUTICALS USA, INC
13.6.1. Key Facts
13.6.2. Business Description
13.6.3. Products and Services
13.6.4. Financial Overview
13.6.5. SWOT Analysis
13.6.6. Key Developments
13.7. ANTARES PHARMA
13.7.1. Key Facts
13.7.2. Business Description
13.7.3. Products and Services
13.7.4. Financial Overview
13.7.5. SWOT Analysis
13.7.6. Key Developments
13.8. MERCK KGAA
13.8.1. Key Facts
13.8.2. Business Description
13.8.3. Products and Services
13.8.4. Financial Overview
13.8.5. SWOT Analysis
13.8.6. Key Developments
13.9. OWEN MUMFORD
13.9.1. Key Facts
13.9.2. Business Description
13.9.3. Products and Services
13.9.4. Financial Overview
13.9.5. SWOT Analysis
13.9.6. Key Developments
13.10. BIOGEN
13.10.1. Key Facts
13.10.2. Business Description
13.10.3. Products and Services
13.10.4. Financial Overview
13.10.5. SWOT Analysis
13.10.6. Key Developments
14. APPENDIX
14.1. ABOUT THE INSIGHT PARTNERS
14.2. GLOSSARY OF TERMS
1. Eisai Co., Ltd
2. Viatris Inc
3. Ypsomed
4. Amgen, Inc
5. BD
6. Teva Pharmaceuticals USA, Inc
7. Antares Pharma
8. Merck KGaA
9. Owen Mumford
10. Biogen
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.